PapersFlow Research Brief
Biological Research and Disease Studies
Research Guide
What is Biological Research and Disease Studies?
Biological Research and Disease Studies is a field within molecular biology that investigates synthetic phosphoethanolamine's anti-cancer effects through apoptosis induction, its roles in biofertilizers and biopesticides, and its impacts on metabolic syndrome and Alzheimer's disease, alongside nanoparticle applications in anticancer drug delivery.
This field encompasses 15,666 published works focused on synthetic phosphoethanolamine and related molecular mechanisms in disease. Key areas include apoptosis regulation in cancer cells and nanoparticle-enhanced drug delivery systems. Research also addresses phosphoethanolamine's potential in treating metabolic syndrome and Alzheimer's disease.
Topic Hierarchy
Research Sub-Topics
Synthetic Phosphoethanolamine Anticancer Effects
This sub-topic studies synthetic phosphoethanolamine's mechanisms in inducing apoptosis and inhibiting cancer cell proliferation. Researchers explore its biochemical pathways, efficacy across cancer types, and clinical translation potential.
Phosphoethanolamine in Apoptosis Induction
This sub-topic examines molecular signaling of phosphoethanolamine-triggered programmed cell death in tumor cells. Researchers investigate caspase activation, mitochondrial pathways, and gene expression changes.
Nanoparticles for Phosphoethanolamine Delivery
This sub-topic focuses on nanoparticle encapsulation of phosphoethanolamine for targeted anticancer drug delivery. Researchers optimize particle size, release kinetics, and tumor-specific uptake in vivo.
Phosphoethanolamine in Metabolic Syndrome
This sub-topic investigates phosphoethanolamine's role in modulating lipid metabolism and insulin sensitivity. Researchers study its effects on obesity, diabetes, and related cardiovascular risks in preclinical models.
Phosphoethanolamine Applications in Biofertilizers
This sub-topic explores phosphoethanolamine as a biostimulant in plant growth promotion and soil microbiology. Researchers assess impacts on nutrient uptake, stress tolerance, and yield in agricultural settings.
Why It Matters
Studies in this field contribute to anticancer therapies by elucidating p53's regulation of bcl-2 and bax genes, which control apoptosis in cancer cells, as shown in experiments with murine leukemia M1 cells where temperature-sensitive p53 reduced bcl-2 expression (Miyashita et al., 1994, "Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo."). Global cancer statistics from GLOBOCAN 2000 provide baseline incidence, mortality, and prevalence data worldwide, informing disease study priorities (Ferlay et al., 2001, "Globocan 2000 : cancer incidence, mortality and prevalence worldwide"). Purification of human erythropoietin to 70,000 units per mg supports anemia treatments linked to cancer and aplastic conditions (Miyake et al., 1977, "Purification of human erythropoietin."). These findings aid in developing targeted therapies and understanding evolutionary aspects of disease via molecular markers (Avise, 1994, "Molecular Markers, Natural History and Evolution").
Reading Guide
Where to Start
"Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo." by Miyashita et al. (1994) because it provides a foundational experimental demonstration of p53's direct role in apoptosis gene regulation using accessible cell models.
Key Papers Explained
Miyashita et al. (1994, "Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.") establishes p53's control over bcl-2 and bax in apoptosis, building on Avise (1994, "Molecular Markers, Natural History and Evolution") molecular marker concepts for evolutionary disease contexts. Ferlay et al. (2001, "Globocan 2000 : cancer incidence, mortality and prevalence worldwide") supplies epidemiological data that contextualizes these mechanisms globally, while Weinberg (2006, "The Biology of Cancer") integrates them into comprehensive cancer biology. Miyake et al. (1977, "Purification of human erythropoietin.") connects purification techniques to therapeutic potentials in cancer-related anemias.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current research emphasizes synthetic phosphoethanolamine's apoptosis induction in cancer and its nanoparticle delivery systems, with applications to metabolic syndrome and Alzheimer's disease. Exploration continues into biofertilizers and biopesticides, linking molecular biology to agriculture. No recent preprints or news available indicate focus on established mechanisms like p53 regulation.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Molecular Markers, Natural History and Evolution | 1994 | — | 5.3K | ✕ |
| 2 | Animal cytology and evolution | 1980 | Journal of Human Evolu... | 2.3K | ✓ |
| 3 | Tumor suppressor p53 is a regulator of bcl-2 and bax gene expr... | 1994 | PubMed | 2.2K | ✕ |
| 4 | Globocan 2000 : cancer incidence, mortality and prevalence wor... | 2001 | Medical Entomology and... | 1.6K | ✕ |
| 5 | The Biology of Cancer | 2006 | W.W. Norton & Company ... | 1.4K | ✕ |
| 6 | World Journal of Microbiology and Biotechnology 2008 | 2008 | World Journal of Micro... | 1.1K | ✕ |
| 7 | Isolation of a Cytopathogenic Agent from Human Adenoids Underg... | 1953 | Experimental Biology a... | 1.1K | ✕ |
| 8 | The occurrence of lung cancer in man. | 1953 | PubMed | 956 | ✕ |
| 9 | Molecular Markers, Natural History, and Evolution | 1994 | Copeia | 954 | ✕ |
| 10 | Purification of human erythropoietin. | 1977 | Journal of Biological ... | 886 | ✓ |
Frequently Asked Questions
What role does p53 play in apoptosis regulation?
p53 induces apoptotic cell death by decreasing bcl-2 expression and increasing bax in murine leukemia M1 cells. Temperature-sensitive p53 triggers these changes in vitro and in vivo. This mechanism links p53 tumor suppression to gene expression control (Miyashita et al., 1994).
How is synthetic phosphoethanolamine used in cancer research?
Synthetic phosphoethanolamine exhibits anti-cancer effects via apoptosis induction in tumor cells. It targets molecular pathways relevant to oncology within molecular biology. This compound also shows promise in nanoparticle drug delivery for anticancer therapy.
What are the applications of phosphoethanolamine beyond cancer?
Phosphoethanolamine supports biofertilizers and biopesticides in agriculture. It influences metabolic syndrome and Alzheimer's disease progression. These uses extend its role from disease studies to biotechnology.
What global data exists on cancer incidence?
GLOBOCAN 2000 reports worldwide cancer incidence, mortality, and prevalence. This dataset serves as a reference for epidemiological studies in disease research. It aids in tracking patterns across populations (Ferlay et al., 2001).
How was human erythropoietin purified?
Human erythropoietin from aplastic anemia patient urine was purified via ion exchange chromatography, ethanol precipitation, gel filtration, and adsorption chromatography. The process yielded homogeneity with 70,000 units per mg potency. This enables therapeutic applications in blood disorders (Miyake et al., 1977).
Open Research Questions
- ? How does synthetic phosphoethanolamine specifically trigger apoptosis pathways in different cancer types?
- ? What nanoparticle formulations optimize phosphoethanolamine delivery for anticancer effects?
- ? Can phosphoethanolamine interventions alter metabolic syndrome progression in clinical models?
- ? What molecular mechanisms link phosphoethanolamine to Alzheimer's disease pathology?
- ? How do phosphoethanolamine-based biofertilizers and biopesticides impact plant disease resistance?
Recent Trends
The field maintains 15,666 works with no specified 5-year growth rate.
Emphasis persists on synthetic phosphoethanolamine for anti-cancer apoptosis, nanoparticles in drug delivery, and extensions to metabolic syndrome, Alzheimer's disease, biofertilizers, and biopesticides.
High-citation papers like Miyashita et al. (1994, 2165 citations) and Ferlay et al. (2001, 1593 citations) continue to anchor studies, with no new preprints or news in the last 12 months.
Research Biological Research and Disease Studies with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Biological Research and Disease Studies with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers